Treatment of obesity in polycystic ovary syndrome: A position statement of the androgen excess and polycystic ovary syndrome society. Fertility and Sterility, 92 , 1966-1982. doi: 10.1016/j ...

Eggs and embryos from people with polycystic ovary syndrome have altered patterns of so-called epigenetic tags, which could explain how the condition is inherited ...

Polycystic ovarian syndrome is the most common hormonal disorder among women of reproductive age and can cause infertility. ... Polycystic ovary disease . Functional ovarian hyperandrogenism .

The polycystic ovary syndrome (PCOS) is a condition characterized by hyperandrogenism and chronic oligo-anovulation. However, many features of the metabolic syndrome are inconsistently present in ...

The research revealed widespread disruptions in the activity of genes responsible for early embryonic genome activation, metabolic processes, epigenetic regulation, and chromatin structure in embryos ...

Polycystic ovary syndrome, or PCOS, is a common illness that causes a myriad of symptoms. That has made it complex to treat, but more funding for research could alleviate that problem.

These biological changes appear to impair endometrial health , disrupting embryo implantation and leading to poor reproductive outcomes. Affecting nearly 20% of women of childbearing age worldwide, ...

Researchers in France have developed an antibody that blocks AMH, reversing PCOS symptoms in mice and opening the door to future human trials.

Polycystic ovary syndrome silently affects millions of women worldwide, yet remains persistently misunderstood within healthcare systems designed to identify and treat it.

Polycystic ovary syndrome is a common hormonal disorder among women, yet often goes underdiagnosed by health care providers. Some women have few, if any, symptoms.

Novel research presented at the 41st annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) has ...